Males testosterone reduction

Permethrin may behave like estrogen in females but antiandrogen in males when administered to immature female and male rats at 10-800 mg/kg [154]. Treatment of rats with permethrin at 10 mg/kg/day during gestation produced fetal death and feminization of male fetuses [155]. Reductions in sperm count and motility and in serum testosterone were noted in a 6-week repeated dose study in mice at 35 mg/kg/day. Permethrin may cause mitochondrial membrane impairment in Leydig cells, resulting in inhibition of testosterone biosynthesis [156]. 

Testolactone is a synthetic drug related to testosterone. It is used for palliative treatment of advanced breast cancer in postmenopausal women and in women who have had their ovaries removed. The principal action of testolactone is reported to be inhibition of steroid aromatase activity and the reduction in estrone synthesis. The most common adverse effects are nausea, vomiting, and anorexia. An advantage is that it does not cause women to develop male characteristics such as a deep voice or facial hair. 

G. Other applications Limited data show some beneficial effects of leuprolide in the treatment of breast cancer. According to Micromedex, there is good documentation that leuprolide is effective for bowel pain and nausea associated with irritable bowel syndrome. Leuprolide has been used for controlled ovarian hyperstimulation to enhance the in vitro fertilization-embryo transfer procedure. In endometriosis, the goal of treatment is pain relief and reduction of endometriotic lesions. In children with central precocious puberty, stimulated and basal gonadotropins are reduced to prepubertal levels. Testosterone and estradiol are reduced to prepubertal levels in males and females, respectively. 

A number of reproductive effects, including decreased fertility, damage to the gonads, and alterations in hormone levels, have been observed in male and female animals orally exposed to 2,3,7,8-TCDD. In male rats, a dose- and time-dependent reduction of serum testosterone and dihydrotestosterone levels was observed after acute oral exposure to 2,3,7,8-TCDD (Mebus et al. 1987 Moore et al. 1985, 1991). Furthermore, male rats had decreased weight of seminal vesicles following oral exposure to... 

Definitive evidence that dihydrotestosterone (DHT) is a potent androgen with its own important physiological and pathophysiological actions, separate from those of testosterone, was provided by two reports in 1974 of a rare inborn disorder of male phenotypic sexual differentiation caused by a deficiency in 5a-reductase, the enzyme that converts testosterone to DHT. The reduction in the conversion of testosterone to DHT by 5a-reductase, which underlies this syndrome, leads to a specific developmental defect in the formation of the male external genitalia and the prostate. Males with this genetic disorder exhibit a striking phenotype, in which the internal genitalia are normal... 

Initially, when spirorenone was tested in low doses on a male human, an unambiguous reduction of the subject s testosterone level was detected. The reason for this change was provided by pharmacokinetic monitoring, wherein it was realized that in humans and in monkeys, unlike other species, spirorenone was metabolized exclusively to 1,2-dihydrospirorenone (drospirenone), by the action of a A -hydrase (Fig. 17.5). 

---